Biology subjects

Duhamel, G. E.

Publications and source records attributed to Duhamel, G. E..

3 recordsLinked to original sources

bioRxiv2026

Feline mammary carcinomas display evidence of stemness, epithelial-mesenchymal plasticity, and metastasis-associated M2-like macrophage infiltration

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer-a consequence of high proliferation rates, stemness, epithelial-mesenchymal plasticity, and immune evasion. Feline mammary carcinomas (FMCs) are spontaneous mammary gland cancers associated with high rates of metastasis and death. The aggressive biological behavior of FMCs, as well as their lack of expression of hormone receptors, make FMCs an excellent naturally-occurring model of human triple-negative breast cancer (TNBC). Therefore, we investigated whether FMCs of increasing histologic grade (I-III) harbor characteristics comparable to human TNBC. We performed immunohistochemistry using markers of proliferation (Ki67), stemness (Sox2), and epithelial-mesenchymal plasticity (E-cadherin, vimentin). We found that FMCs expressed high levels of Sox2 and vimentin together with a grade-associated increase in Ki67 expression. Apart from these cancer cell-intrinsic properties, knowledge on the tumor microenvironment of FMCs is limited. To this end, we assessed the presence of T-cells (CD3), total macrophages (Iba1), and immunosuppressive M2-like macrophages (CD204) in FMCs. High-grade FMCs showed increased M2-like macrophage infiltration. Moreover, samples with evidence of vascular invasion and lymph node metastasis displayed increased total and M2-like macrophage infiltration. These findings suggest that the presence of intratumoral macrophages is associated with the biological aggressiveness and metastatic potential of FMCs. Taken together, our results support FMCs as a translational model of human TNBC.

cancer biology↗

bioRxiv2026

Neuroepithelial reprogramming and ERBB vulnerability in canine acanthomatous ameloblastoma

Canine acanthomatous ameloblastoma (CAA) is a locally invasive benign oral neoplasm that is difficult to distinguish from canine oral squamous cell carcinoma (COSCC) due to overlapping clinical, radiologic, and histologic features. Although both tumors exhibit MAPK pathway activation, their mutational landscapes are distinct. Furthermore, previous studies using bulk RNA sequencing (RNA-seq) have demonstrated pronounced differences in programs related to, among others, hypoxia, PI3K-AKT signaling, and cell proliferation. However, these bulk studies lacked the resolution to elucidate the cellular heterogeneity of CAA relative to COSCC. We therefore performed single-nucleus RNA-seq to define the cellular gene expression landscape of CAA, COSCC, and healthy gingiva. Across [~]205,000 nuclei, we identified major epithelial, immune, endothelial, and mesenchymal populations, as well as two epithelial subtypes uniquely enriched in CAA. The CAA-specific keratinocytes exhibited a neuronal-like expression program defined by synaptic regulators, KRAS-associated signaling pathways, and markedly elevated expression of PEG3, ERBB4, GABRB1, MAGI2, and CASK. These findings were validated by bulk RNA-seq, qPCR, and immunohistochemistry, which demonstrated strong nuclear localization of PEG3 exclusively in CAA epithelium. A kinase inhibitor screen independently identified ERBB4 as a candidate therapeutic vulnerability, and pharmacologic inhibition with neratinib was effective. Together, these findings reveal a previously unrecognized neuroepithelial cell state that defines CAA, distinguishes it from COSCC, and reveals unique diagnostic and therapeutic signaling dependencies. Given the molecular and histopathologic parallels between CAA and human ameloblastoma, these data further position CAA as a naturally occurring comparative model for studying ameloblastoma biology and therapeutic vulnerabilities. Significance StatementCanine acanthomatous ameloblastoma (CAA) is a common locally aggressive oral neoplasm often misdiagnosed as canine oral squamous cell carcinoma (COSCC) due to overlapping clinical, radiologic, and histologic features. Using single-nucleus RNA sequencing of CAA, COSCC, and healthy gingiva, we resolve the microenvironment of these tumors and detect two epithelial subpopulations unique to CAA. These CAA-specific keratinocytes exhibit a neuroepithelial-like signature characterized by synaptic regulators, KRAS-associated signaling, and elevated PEG3 and ERBB4 expression. Functional kinase inhibitor screening of patient derived microtumor slices independently converged on ERBB4 as an effective therapeutic target. Together, our study provides a molecular framework for distinguishing CAA from COSCC and establishes a comparative oncology model with translational relevance to human ameloblastoma and other ERBB-driven epithelial neoplasms.

cancer biology↗

bioRxiv2021

The asymmetric Pitx2 regulates intestinal muscular-lacteal development and protects against fatty liver disease

Intestinal lacteals are the essential lymphatic channels for absorption and transport of dietary lipids and drive pathogenesis of debilitating metabolic diseases. Yet, organ-specific mechanisms linking lymphatic dysfunction to disease etiology remain largely unknown. In this study, we uncover a novel intestinal lymphatic program that is linked to the left-right (LR) asymmetric transcription factor Pitx2. We show that deletion of the asymmetric Pitx2 enhancer, ASE, alters normal lacteal development through the lacteal-associated contractile smooth muscle lineage. ASE deletion leads to abnormal muscle morphogenesis induced by oxidative stress, resulting in impaired lacteal extension and defective lymphatic-dependent lipid transport. Surprisingly, activation of lymphatic-independent trafficking directs dietary lipids from the gut directly to the liver, causing diet-induced fatty liver disease. In summary, our studies reveal the molecular mechanism linking gut lymphatic development to the earliest symmetry-breaking Pitx2 and highlight the important relationship between intestinal lymphangiogenesis and gut-liver axis. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/447753v1_ufig1.gif" ALT="Figure 1"> View larger version (41K): org.highwire.dtl.DTLVardef@1a7e81corg.highwire.dtl.DTLVardef@77915forg.highwire.dtl.DTLVardef@1e91610org.highwire.dtl.DTLVardef@1a7911d_HPS_FORMAT_FIGEXP M_FIG GRAPHICAL ABSTRACT C_FIG HIGHLIGHTS[~] Gut lymphangiogenesis is linked to Pitx2-driven LR asymmetry [~]Lacteal-associated smooth muscle requires ASE [~]ASE deletion leads to redox imbalance in intestinal smooth muscle lineage [~]ASE is required for the normal route of dietary lipid transport [~]Pitx2ASE/ASE neonates develop diet-induced fatty liver disease

developmental biology↗